Example sentences of "[am/are] [verb] by the [noun pl] [unc] " in BNC.
Next pageNo | Sentence |
---|---|
1 | Whatever attitudes Protestants in Easton might have towards the police because of Northern Ireland 's social and political divisions , these are undercut by the police 's pursuit of crime and its perpetrators , so that some Protestant in Easton encounter the police in situations which encourage negative views as a result of the ordinary criminal activity they engage in . |
2 | But on the whole it is easy to value paintings by Japanese artists as they paint similar subjects , and new prices are set by the dealers ' auction which takes place once a month at the Tokyo Bijutsu Club , of which most big dealers are members . |
3 | Alternatively , these assets are left untouched , and are inherited by the grandparents ' children . |
4 | Other delays in obtaining access to the goods are caused by the importers ' need to produce an ever increasing number of documents . |
5 | The overseas office of an MNP is in a slightly different position ; the solicitors practising from that office ( including all the solicitor partners , whether resident overseas or not ) are governed by the Solicitors ' Overseas Practice Rules 1990 , and solicitor partners will be responsible for ensuring the office 's compliance . |
6 | The 158 or so student societies are funded by the Students ' Association . |
7 | People enquiring about the Allied Trust Tessa and the company 's status are accurately told by employees that Tessa deposits are covered by the deposit-holders ' protection scheme , which guarantees up to 75% of the first £20,000 of an investor 's money if a bank fails . |
8 | However , what is of interest is that the other two comparative static propositions of the theory are confirmed by the subjects ' behaviour : output rises with an increase in σ and falls with an increase in k . |
9 | But they sell them without an import licence — which is illegal , In practice , the licences are monopolised by the brands ' parent companies , who can afford the extensive clinical trials on the drugs that are necessary for licensing . |